Evidence map›Paper›PMID 20335532›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

CD22 expression mediates the regulatory functions of peritoneal B-1a cells during the remission phase of contact hypersensitivity reactions.

Hiroko Nakashima, Yasuhito Hamaguchi, Rei Watanabe, Nobuko Ishiura, Yoshihiro Kuwano, Hitoshi Okochi, Yoshimasa Takahashi, Kunihiko Tamaki, Shinichi Sato, Thomas F Tedder and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Noncanonical B Cells: Characteristics of Uncharacteristic B Cells.Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  3. Review
  4. Resident Memory B Cells in Barrier Tissues.Frontiers in immunology · 2022
    Review
  5. Article
  6. Contact dermatitis.Nature reviews. Disease primers · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Skin-Associated B Cells in Health and Inflammation.Journal of immunology (Baltimore, Md. : 1950) · 2019
    Review
  12. CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. New insights into heterogeneity of peritoneal B-1a cells.Annals of the New York Academy of Sciences · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Hiroko NakashimaDepartment of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
Yasuhito Hamaguchi
Rei Watanabe
Nobuko Ishiura
Yoshihiro Kuwano
Hitoshi Okochi
Yoshimasa Takahashi
Kunihiko Tamaki
Shinichi Sato
Thomas F Tedder
Manabu Fujimoto
The University of Tokyo · JPKanazawa University · JPDuke Medical Center · USNational Institute of Infectious Diseases · JP

Funding

Supplement - Inflammatory Triggers in B Cell AutoimmunityU19AI056363 · NIAID · DUKE UNIVERSITY · PI ST. CLAIR, EUGENE WILLIAM · 2003 to 2017
$35.3M
CD22 Regulation of B Lymphocyte Function and SurvivalR01CA096547 · NCI · DUKE UNIVERSITY · PI TEDDER, THOMAS F · 2003 to 2007
$1.3M
MS4A Family Members in Health and DiseaseR01CA105001 · NCI · DUKE UNIVERSITY · PI TEDDER, THOMAS F · 2004 to 2008
$1.2M
NCI NIH HHS CA105001NCI NIH HHS CA96547NCI NIH HHS R01 CA096547NCI NIH HHS R01 CA105001NIAID NIH HHS AI56363NIAID NIH HHS U19 AI056363
6 · The paper itself

Abstract

Although contact hypersensitivity (CHS) has been considered a prototype of T cell-mediated immune reactions, recently a significant contribution of regulatory B cell subsets in the suppression of CHS has been demonstrated. CD22, one of the sialic acid-binding immunoglobulin-like lectins, is a B cell-specific molecule that negatively regulates BCR signaling. To clarify the roles of B cells in CHS, CHS in CD22(-/-) mice was investigated. CD22(-/-) mice showed delayed recovery from CHS reactions compared with that of wild-type mice. Transfer of wild-type peritoneal B-1a cells reversed the prolonged CHS reaction seen in CD22(-/-) mice, and this was blocked by the simultaneous injection with IL-10 receptor Ab. Although CD22(-/-) peritoneal B-1a cells were capable of producing IL-10 at wild-type levels, i.p. injection of differentially labeled wild-type/CD22(-/-) B cells demonstrated that a smaller number of CD22(-/-) B cells resided in lymphoid organs 5 d after CHS elicitation, suggesting a defect in survival or retention in activated CD22(-/-) peritoneal B-1 cells. Thus, our study reveals a regulatory role for peritoneal B-1a cells in CHS. Two distinct regulatory B cell subsets cooperatively inhibit CHS responses. Although splenic CD1d(hi)CD5(+) B cells have a crucial role in suppressing the acute exacerbating phase of CHS, peritoneal B-1a cells are likely to suppress the late remission phase as "regulatory B cells." CD22 deficiency results in disturbed CHS remission by impaired retention or survival of peritoneal B-1a cells that migrate into lymphoid organs.

Indexed as

Adoptive TransferAnimalsB-Lymphocyte SubsetsCell MovementCells, CulturedContact InhibitionDermatitis, ContactInterleukin-10MiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutPeritoneumSialic Acid Binding Ig-like Lectin 2Cd22 protein, mouseInterleukin-10Sialic Acid Binding Ig-like Lectin 2

Identifiers

PMID20335532
PMCPMC3773934
OpenAlexW1578117262

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.